Abstract:Introduction:The pathophysiological substrate for initiation and maintenance of atrial fibrillation (AF) depends on structural atrial changes in the majority of patients.Nevertheless, a systematic characterisation of disease-specific atrial cardiomyopathies is missing.Purpose: In this study, we aimed to determine the specific impact of hypertension, type-2 diabetes mellitus (T2DM), and ageing on atrial molecular biology by using animal models of human T2DM, Zucker diabetic fatty (ZDF) rat and of hypertension, spontaneously hypertensive rat (SHR).Methods: The atrial remodelling was studied at different stages of hypertension and T2DM.In ZDF rats two time points were chosen: shortly after onset of diabetes (obese ZDF n¼15 vs. lean ZDF n¼12) and in an advanced stage of diabetes (obese ZDF n¼14 vs. lean ZDF n¼12).In SHR, the hypertension-dependent changes were investigated at the initial stage of hypertrophy (3Mo., SHR n¼ 13 vs.WKY n¼13), established hypertrophy (6-8 Mo, SHR n¼ 18 vs.WKY n¼17), and at the advanced stage of hypertrophy (15 Mo, SHR n¼ 10 vs. WKY n¼ 10).To characterise atrial remodelling in the rat disease models we performed detailed analysis using transcriptome technique, real time quantitative PCRs, Western blots and ELISA/EIA assays.Results: Our data revealed that hypertensive atrial tissue displayed activated endothelin (ET)-and angiotensin II-dependent signalling.The hypertensive atrial tissue showed elevated levels of active ET (0.1560.02 vs. 0.0960.01pg/mg tissue, p<0.05) and ANGII (14.161.2 vs. 8.361.4 pg/mg tissue, p<0.01) in atrial homogenates.In line with this, we identified an increased mRNA level of important molecules in both systems: ACE, chymase, ETAR, ET (LA: 4.861.2 vs. 1.060.2p<0.05).Moreover, the atrial tissue from SHR was characterised by constantly activated MAP kinases: ERK, p38, and activated NF-jB signal pathway.In addition, the hypertensive atrial tissue demonstrated an increased expression of hypertrophic (MYH7, BNP), fibrotic (TGFb, fibronectin, collagens), inflammatory (IL6, IL-8, ICAM-1), and pro-coagulatory (PAI-1) molecules.Whereas the remodelling process in hypertensive atria was restricted to the left atrium, in T2DM it was present in both atria.In contrast to hypertensive atrial tissue, the onset and the progression of T2DM were characterised by oxidative stress (LOX1: LA 2.160.3 vs. 160.1,RA 2.560.4 vs. 160.1,p<0.05) that facilitated apoptotic (BAX, caspase3), inflammatory (TNFa, IL6, IL8), and pro-thrombotic (PAI-1) changes in atrial tissue.Conclusions: Aetiological factors cause distinct atrial cardiomyopathies.The knowledge of disease-specificity in atrial molecular biology will help to identify aetiologyspecific therapeutic approaches and therapeutic drug targets to prevent AF.

Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice

Ang II Enhances Atrial Fibroblast Autophagy and Promotes Atrial Remodeling Through the AT1-ERK-mTOR Signaling Pathway

CXCL12/CXCR4 axis as a key mediator in atrial fibrillation via bioinformatics analysis and functional identification

CXCL1–CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration

Cross-talk Between Macrophages and Atrial Myocytes in Atrial Fibrillation

Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation via a potential NOX/CaMKII mechanism

Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation <i>via</i> a potential NOX/CaMKII mechanism

CCL24/CCR3 Axis Plays a Central Role in Angiotensin II–induced Heart Failure by Stimulating M2 Macrophage Polarization and Fibroblast Activation

C-Reactive Protein Promotes Cardiac Inflammation and Fibrosis in Angiotensin Ii-Induced Hypertensive Cardiovascular Diseases

Cold-inducible RNA-binding Protein Modulates Atrial Fibrillation Onset by Targeting Multiple Ion Channels.

Blockage of C-X-C Motif Chemokine Receptor 2 (CXCR2) Suppressed Uric Acid (UA)-Induced Cardiac Remodeling

Recruited macrophages elicit atrial fibrillation

Chronic Inhibition of the Sigma-1 Receptor Exacerbates Atrial Fibrillation Susceptibility in Rats by Promoting Atrial Remodeling.

Involvement of ERK1/2 in Cx43 depression induced by macrophage migration inhibitory factor in atrial myocytes.

Krüppel-Like Factor 15 Modulates CXCL1/CXCR2 Signaling-Mediated Inflammatory Response Contributing to Angiotensin II-Induced Cardiac Remodeling

Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice

Mechanism of Macrophage Migration Inhibitory Factor-Induced Decrease of T-Type Ca2+Channel Current in Atrium-Derived Cells

Increased Expression of Mineralocorticoid Receptor in Human Atrial Fibrillation and a Cellular Model of Atrial Fibrillation

YY1-induced upregulation of lncRNA KCNQ1OT1 regulates angiotensin II-induced atrial fibrillation by modulating miR-384b/CACNA1C axis.

Selective Blockade of Interleukin-6 Trans-signaling

194Baseline Echocardiography-Indicated Impaired Atrial Function Predicts Reoccurrence and Thromboembolic Risks after Catheter Ablation of Atrial Fibrillation